Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Theranostics|May 23, 2017
[18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's DiseaseMichelle L James, Nadia P Belichenko, Adam J Shuhendler, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 23, 2024
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse modelAmira Latif-Hernandez, Tao Yang, Robert R Butler, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 22, 2023
Open drug discovery in Alzheimer's diseaseAlison D Axtman, Paul E Brennan, Tristan Frappier-Brinton, et al.Neuron|May 25, 2019
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive ImpairmentAnna C Geraghty, Erin M Gibson, Reem A Ghanem, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2024
Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domainsGregory A Cary, Jesse C Wiley, Jake Gockley, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2015
PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamideMichelle L James, Nadia P Belichenko, Thuy-Vi V Nguyen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2015
B-lymphocyte-mediated delayed cognitive impairment following strokeKristian P Doyle, Lisa N Quach, Montse Solé, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2019
Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammationDanielle A Simmons, Frederick M Lartey, Emil Schüler, et al.The Journal of Pharmacology and Experimental Therapeutics|December 11, 2021
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves RecoveryThuy-Vi V Nguyen, Rachel H Crumpacker, Kylie E Calderon, et al.Nature Communications|April 17, 2019
Early life stress disrupts intestinal homeostasis via NGF-TrkA signalingHoi Leong Xavier Wong, Hong-Yan Qin, Siu Wai Tsang, et al.Pageof 12